Pandorum Technologies

ApplicationBengaluru, IndiaFounded 2011

Bioprinting pioneer creating lab-grown human tissues for drug discovery and regenerative medicine

CEO / Founder
Tuhin Bhowmick
Team Size
50-100
Stage
Series B funded, pre-revenue stage developing flagship therapy
Total Funding
$36.8M
Latest Round
Series B
Key Investors
Protons Corporate, Ashish Kacholia, Indian Angel Network, 021 Capital, BTB Venture

Technology & Products

Key Products

Engineered liver models, corneal models, Kuragenx "Liquid Cornea" therapy, proprietary bioprinting platform

Technological Advantage

Proprietary bioprinting platform for high-precision tissue engineering

Market & Competition

Target Customers

Pharmaceutical companies, research institutions, hospitals

Industry Verticals

Pharmaceuticals, Biotechnology, Healthcare, Research

Competitors

Organovo, Aspect Biosystems, CELLINK